In male SD rats with pulmonary hypertension (PHA), MG (100 mg kg−1, i.p. injection) exerted a therapeutic effect of PHA by altering the Akt/ERK1/2/glycogen synthase kinase 3β (GSK3β)-catenin pathway. Here, AKT1 is linked to Pelger-Huet anomaly.